Willow vs LumiMeds

Willow posts flat cash rates: compounded semaglutide at $299 per month and tirzepatide starting at $399 with consults, medication, and 2-day shipping included. HSA/FSA payments are accepted and there are no membership fees, though higher tirzepatide strengths narrow the savings.

LumiMeds keeps pricing simple—GLP-1 plans at $189/month or $399 for three months, and GLP-1/GIP tiers at $279/month or $399/$649 bundles across doses. Non-refundable $60 cancellations, no refunds after shipment, and 28-day notice on subscriptions add friction.

Licensed clinicians titrate compounded GLP-1s from partner pharmacies and provide quick message-based follow-up. Because Willow does not name those pharmacies and compounded products vary, we advise requesting COAs and cold-chain details.

The site repeatedly flags that compounded GLP-1s aren’t FDA-approved and leans on a 503B outsourcing facility with 503A fulfillment. The FDA’s September 2025 warning letter about LumiMeds’ compounded GLP-1/GIP marketing introduces regulatory risk we continue to monitor.

Enrollment is a same-day online intake covering history, contraindications, identity, and state eligibility. Once approved, prescriptions route straight to the pharmacy and most members receive tracking soon after.

Patients move through a three-step flow with target ~48-hour provider review and clear guidance. Dual portals and vague shipping timelines cause some friction even though phone and email contacts are published.

Willow supplies compounded semaglutide and tirzepatide in injectables and sublingual tablets plus the GLP-90 program. Clinicians individualize dosing, and availability can shift by state because these are compounded formulations.

Offerings focus on compounded semaglutide and tirzepatide, leaving a concise menu geared to GLP-1 therapy. Patients seeking other formulations will need alternatives.

Partner pharmacies dispense and ship via free 2-day shipping when inventory is available, with tracking pushed through the portal. Delivery windows depend on production queues and cold-chain handling, so expectations stay conservative.

Public policies reference pharmacy fulfillment but rarely commit to ship speeds or inventory expectations. Delivery likely varies by state and stock, so we score fulfillment cautiously.

Unlimited in-portal messaging handles dose adjustments and side effects with replies typically inside 24 hours. Reviews are positive overall, though urgent shipping issues can be harder to escalate without phone support.

LumiMeds lists phone and email support and maintains an active social presence with mid–high 4-star aggregated reviews. Complaints concentrate on portal changes and fulfillment timing.

The dashboard is mobile-first with clear status updates and tracking, minimizing friction. Messaging handles titrations quickly, but first-time GLP-1 patients may need more education than the streamlined flow provides.

The experience mirrors the three-step enrollment and dual portals, keeping the process fast but occasionally disjointed. Lack of explicit shipping SLAs leaves some users guessing about timing.